Dr. Todd Peterson is currently Chief Technology Officer at Synthetic Genomics, Inc. (SGI) based in La Jolla, California. SGI is a leader in synthetic biology and applied genomics technologies developing breakthrough solutions for major global issues. Dr. Peterson has >25 years of experience in industrial research and development in the areas of molecular biology, nucleic acids and genomics product and technology development. His experience encompasses clinical diagnostics, life science research tools and pharmaceutical discovery technologies and market segments. Prior to joining SGI, Dr. Peterson led Genomics and Synthetic Biology R&D at Life Technologies, a global leader in life science research tools, for 10 years. Prior to Life Technologies, Dr. Peterson held research and development positions with increasing responsibilities at Genicon Sciences, Trega Biosciences, Hybritech and Gen-Probe where he focused on product and technology research, development and commercialization. Dr. Peterson was a postdoctoral fellow at the Max Planck Institute in Cologne Germany and received his Ph.D. in Microbiology at the University of Southern California School of Medicine.